Nitroindazole extended release - Beyond Air
Alternative Names: 7-NI; 7-nitroindazole; Neuronal nitric oxide synthase inhibitor - Beyond Air; nNOS inhibitor - Beyond AirLatest Information Update: 20 Sep 2023
At a glance
- Originator Hebrew University of Jerusalem
- Developer Beyond Air
- Class Anti-inflammatories; Antiepileptic drugs; Behavioural disorder therapies; Neuroprotectants; Nitro compounds; Small molecules
- Mechanism of Action Nitric oxide synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autistic disorder
Most Recent Events
- 18 Sep 2023 Pharmacodynamic and pharmacokinetics data from preclinical studies in Autism disorder released by Beyond Air
- 07 Aug 2023 Pharmacodynamics data from a preclinical studies in Autism disorder released by Beyond Air
- 15 Jun 2023 Beyond Air in-licenses nitric oxide synthase inhibitors from Hebrew University of Jerusalem